Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Analytical Chemistry|March 27, 2010
Focusing of low-molecular-mass heparins in polycationic polyacrylamide matricesGleb Zilberstein, Ilya Shlar, Leonid Korol, et al.
Thrombosis and Haemostasis|November 6, 2009
Structural features of low-molecular-weight heparins affecting their affinity to antithrombinAntonella Bisio, Davide Vecchietti, Laura Citterio, et al.
Molecules (Basel, Switzerland)|December 15, 2018
Structural Features of Heparan Sulfate from Multiple Osteochondromas and ChondrosarcomasNoemi Veraldi, Alessandro Parra, Elena Urso, et al.
Biochemical and Biophysical Research Communications|March 14, 2002
Minimal heparin/heparan sulfate sequences for binding to fibroblast growth factor-1Marco Guerrini, Teresa Agulles, Antonella Bisio, et al.
Thrombosis and Haemostasis|March 24, 2022
Pentosan Polysulfate Inhibits Attachment and Infection by SARS-CoV-2 In Vitro: Insights into Structural Requirements for BindingSabrina Bertini, Anna Alekseeva, Stefano Elli, et al.
Scientific Reports|December 31, 2024
Evolution of SARS-CoV-2 spike trimers towards optimized heparan sulfate cross-linking and inter-chain mobilityJurij Froese, Marco Mandalari, Monica Civera, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 22, 2022
Evidence for Multiple Binding Modes in the Initial Contact Between SARS-CoV-2 Spike S1 Protein and Cell Surface GlycansMichela Parafioriti, Minghong Ni, Maurice Petitou, et al.
JACS Au|April 3, 2023
Glycosaminoglycans: What Remains To Be Deciphered?Serge Perez, Olga Makshakova, Jesus Angulo, et al.
Nature Biotechnology|April 26, 2008
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical eventsMarco Guerrini, Daniela Beccati, Zachary Shriver, et al.
Pageof 3